<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02318433</url>
  </required_header>
  <id_info>
    <org_study_id>14-004033</org_study_id>
    <nct_id>NCT02318433</nct_id>
  </id_info>
  <brief_title>Intra-Articular Dexamethasone to Prevent Post-Traumatic Osteoarthritis: A Pilot Study</brief_title>
  <official_title>Intra-Articular Dexamethasone to Prevent Post-Traumatic Osteoarthritis: A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary aim of the study is to see if a single wrist injection (intra-articular) of
      dexamethasone at the time of treatment will reduce the incidence of early-onset of post
      traumatic osteoarthritis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Our hypothesis is that the intra-articular administration of dexamethasone soon after joint
      injury will prevent the subsequent development of PTOA, and restore normal joint homeostasis.
      We plan to generate the data needed to test this hypothesis in a Phase 0 (pilot) clinical
      trial using patients who have suffered distal radius fractures.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>December 2014</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PTOA incidence</measure>
    <time_frame>3 years</time_frame>
    <description>Primary outcome measure will incidence of post-traumatic osteoarthritis, determined by joint space narrowing, as measured radiologically.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional assessment</measure>
    <time_frame>3 years</time_frame>
    <description>A composite of clinical measurements of grip strength and pinch strength.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient-rated evaluations</measure>
    <time_frame>3 years</time_frame>
    <description>Composite scores from patient-rated evaluations including the Disabilities of the Arm Shoulder and Hand (DASH), the Michigan Hand Questionnaire (MHQ), and the Patient-Rated Wrist Evaluation (PRWE).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Distal Radius Fracture</condition>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Dexamethasone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects receive dexamethasone (4 mg) injection within the radiocarpal joint either in clinic or in the OR.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subjects receive sterile saline (4 mg) injection within the radiocarpal joint either in clinic or in the OR.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <description>Data demonstrates that low doses of dexamethasone preserves chondrocyte viability, protects collagen, and maintains proteoglycan synthesis in cartilage subjected to injurious compression.</description>
    <arm_group_label>Dexamethasone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <arm_group_label>Saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Unstable distal radius fracture

          2. Fracture type AO B1, B2, B3, C1, C2 or C3.

          3. 18-65 years old

          4. Understand and read English

          5. Community dwelling (not in assisted living or NH)

        Exclusion criteria:

          1. Open or bilateral DRF

          2. Associated upper extremity carpal fracture or carpal ligament injuries requiring
             casting or surgical repair at the time of DRF fixation.

          3. Greater than 2 weeks post injury

          4. Neurologic disorders affecting the hand, wrist or arm.

          5. History of permanent dementia, Alzheimer's or other neurologic dx

          6. Substance abuse

          7. Pathologic fractures

          8. Known pregnancy

          9. Radiocarpal joint arthritis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sanjeev Kakar, M.D., M.B.A</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 8, 2014</study_first_submitted>
  <study_first_submitted_qc>December 16, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 17, 2014</study_first_posted>
  <last_update_submitted>December 31, 2015</last_update_submitted>
  <last_update_submitted_qc>December 31, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 1, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Sanjeev (Sanj) Kakar, M.D., M.B.A.</investigator_full_name>
    <investigator_title>PI</investigator_title>
  </responsible_party>
  <keyword>DRF</keyword>
  <keyword>PTOA</keyword>
  <keyword>dexamethasone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Radius Fractures</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

